Current opinion in urology · 2026
Single port transvesical robotic radical prostatectomy.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Soputro Nicolas A, Al-Bayati Abdulrahman, Kaouk Jihad
Аннотация
PURPOSE OF REVIEW: Transvesical single port (SP) robotic radical prostatectomy (RARP) represents a novel minimally invasive surgical technique that is regionalized to the confines of the bladder and promises enhanced perioperative outcomes with improved patient comfort. This review details the surgical techniques, patient selection, and a summary of recently published perioperative, oncological, and functional outcomes of the surgical approach.
RECENT FINDINGS: Since its initial introduction in 2020, transvesical SP-RARP has been increasingly adopted, with early clinical experience demonstrating favorable perioperative outcomes including reduced intraoperative blood loss, low complication rates, high rates of same-day discharges, and reduced postoperative pain. Comparative studies have also demonstrated the SP transvesical approach to offer significantly improved early urinary continence recovery with high rates of immediate continence, while maintaining comparable oncological outcomes and erectile function recovery, as well as providing effective surgical alternatives in patients with a hostile abdomen.
SUMMARY: Leveraging the unique features of the purpose-built SP robotic platform, Transvesical SP-RARP represents a promising surgical approach featuring improved perioperative and functional outcomes, with enhanced patient comfort.
RECENT FINDINGS: Since its initial introduction in 2020, transvesical SP-RARP has been increasingly adopted, with early clinical experience demonstrating favorable perioperative outcomes including reduced intraoperative blood loss, low complication rates, high rates of same-day discharges, and reduced postoperative pain. Comparative studies have also demonstrated the SP transvesical approach to offer significantly improved early urinary continence recovery with high rates of immediate continence, while maintaining comparable oncological outcomes and erectile function recovery, as well as providing effective surgical alternatives in patients with a hostile abdomen.
SUMMARY: Leveraging the unique features of the purpose-built SP robotic platform, Transvesical SP-RARP represents a promising surgical approach featuring improved perioperative and functional outcomes, with enhanced patient comfort.